{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:17:10Z","timestamp":1782386230854,"version":"3.54.5"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T00:00:00Z","timestamp":1680825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gene therapy with AAV vectors carrying genes for neuropeptide Y and its receptor Y2 has been shown to inhibit seizures in multiple animal models of epilepsy. It is however unknown how the AAV serotype or the sequence order of these two transgenes in the expression cassette affects the actual parenchymal gene expression levels and the seizure-suppressant efficacy. To address these questions, we compared three viral vector serotypes (AAV1, AAV2 and AAV8) and two transgene sequence orders (NPY-IRES-Y2 and Y2-IRES-NPY) in a rat model of acutely induced seizures. Wistar male rats were injected bilaterally with viral vectors and 3 weeks later acute seizures were induced by a subcutaneous injection of kainate. The latency until 1<jats:sup>st<\/jats:sup> motor seizure, time spent in motor seizure and latency to status epilepticus were measured to evaluate the seizure-suppressing efficacy of these vectors compared to an empty cassette control vector. Based on the results, the effect of the AAV1-NPY-IRES-Y2 vector was further investigated by in vitro electrophysiology, and its ability to achieve transgene overexpression in resected human hippocampal tissue was evaluated. The AAV1-NPY-IRES-Y2 proved to be better to any other serotype or gene sequence considering both transgene expression and ability to suppress induced seizures in rats. The vector also demonstrated transgene-induced decrease of glutamate release from excitatory neuron terminals and significantly increased both NPY and Y2 expression in resected human hippocampal tissue from patients with drug-resistant temporal lobe epilepsy. These results validate the feasibility of NPY\/Y2 receptor gene therapy as a therapeutic opportunity in focal epilepsies.<\/jats:p>","DOI":"10.1038\/s41434-023-00399-w","type":"journal-article","created":{"date-parts":[[2023,4,7]],"date-time":"2023-04-07T06:02:47Z","timestamp":1680847367000},"page":"649-658","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Combinatorial gene therapy for epilepsy: Gene sequence positioning and AAV serotype influence expression and inhibitory effect on seizures"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7007-8434","authenticated-orcid":false,"given":"Esbj\u00f6rn","family":"Melin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3699-138X","authenticated-orcid":false,"given":"My","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper R.","family":"G\u00f8tzsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Wickham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Alicja","family":"Szczygiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnie","family":"Boender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren H.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Pinborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P. D.","family":"Woldbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merab","family":"Kokaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,7]]},"reference":[{"key":"399_CR1","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/S0140-6736(06)68477-8","volume":"367","author":"JS Duncan","year":"2006","unstructured":"Duncan JS, Sander JW, Sisodiya SM, Walker MC. Adult epilepsy. Lancet. 2006;367:1087\u2013100. https:\/\/doi.org\/10.1016\/S0140-6736(06)68477-8","journal-title":"Lancet"},{"key":"399_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","volume":"88","author":"KM Fiest","year":"2017","unstructured":"Fiest KM, Sauro KM, Wiebe S, Patten SB, Kwon C-S, Dykeman J, et al. Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies. Neurology. 2017;88:296\u2013303. https:\/\/doi.org\/10.1212\/WNL.0000000000003509","journal-title":"Neurology"},{"key":"399_CR3","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1111\/j.1528-1167.2007.01251.x","volume":"48","author":"M Pugliatti","year":"2007","unstructured":"Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P. Estimating the cost of epilepsy in Europe: A review with economic modeling. Epilepsia. 2007;48:2224\u201333. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01251.x","journal-title":"Epilepsia"},{"key":"399_CR4","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/j.1528-1167.2008.01579.x","volume":"49","author":"MC Picot","year":"2008","unstructured":"Picot MC, Baldy-Moulinier M, Daur\u00e8s JP, Dujols P, Crespel A. The prevalence of epilepsy and pharmacoresistant epilepsy in adults: A population-based study in a Western European country. Epilepsia. 2008;49:1230\u20138. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01579.x","journal-title":"Epilepsia"},{"key":"399_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/jnen\/59.10.907","volume":"59","author":"DM Yilmazer-Hanke","year":"2000","unstructured":"Yilmazer-Hanke DM, Wolf HK, Schramm J, Elger CE, Wiestler OD, Bl\u00fcmcke I. Subregional pathology of the amygdala complex and entorhinal region in surgical specimens from patients with pharmacoresistant temporal lobe epilepsy. J Neuropathol Exp Neurol. 2000;59:907\u201320. https:\/\/doi.org\/10.1093\/jnen\/59.10.907","journal-title":"J Neuropathol Exp Neurol"},{"key":"399_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nec.2018.12.005","volume":"30","author":"HFJ Gonz\u00e1lez","year":"2019","unstructured":"Gonz\u00e1lez HFJ, Yengo-Kahn A, Englot DJ. Vagus nerve stimulation for the treatment of epilepsy. Neurosurg Clin N Am. 2019;30:219\u201330. https:\/\/doi.org\/10.1016\/j.nec.2018.12.005","journal-title":"Neurosurg Clin N Am"},{"key":"399_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2019.00005","volume":"13","author":"I D\u2019Andrea Meira","year":"2019","unstructured":"D\u2019Andrea Meira I, Rom\u00e3o TT, Do Prado HJP, Kr\u00fcger LT, Pires MEP, Da Concei\u00e7\u00e3o PO. Ketogenic diet and epilepsy: What we know so far. Front Neurosci. 2019;13:1\u20138. https:\/\/doi.org\/10.3389\/fnins.2019.00005","journal-title":"Front Neurosci"},{"key":"399_CR8","doi-asserted-by":"publisher","unstructured":"West S, Nolan S, Cotton J, Gandhi S, Weston J, Ramirez R, et al. Surgery for epilepsy (Review). Cochrane Database Syst Rev. 2015. https:\/\/doi.org\/10.1002\/14651858.CD010541.pub2. www.cochranelibrary.com.","DOI":"10.1002\/14651858.CD010541.pub2"},{"key":"399_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrneurol.2014.43","volume":"10","author":"DM Kullmann","year":"2014","unstructured":"Kullmann DM, Schorge S, Walker MC, Wykes RC. Gene therapy in epilepsy\u2014is it time for clinical trials. Nat Rev Neurol. 2014;10:300\u20134. https:\/\/doi.org\/10.1038\/nrneurol.2014.43","journal-title":"Nat Rev Neurol"},{"key":"399_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/306584a0","volume":"306","author":"TE Adrian","year":"1983","unstructured":"Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossor MN, Roberts GW, et al. Neuropeptide Y distribution in the human brain. Nature. 1983;306:584\u20136.","journal-title":"Nature"},{"key":"399_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/cne.902440310","volume":"244","author":"C K\u00f6hler","year":"1986","unstructured":"K\u00f6hler C, Eriksson L, Davies S, Chan-Palay V. Neuropeptide Y innervation of the hippocampal region in the rat and monkey brain. J Comp Neurol. 1986;244:384\u2013400. https:\/\/doi.org\/10.1002\/cne.902440310","journal-title":"J Comp Neurol"},{"key":"399_CR12","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/0896-6273(91)90333-U","volume":"7","author":"T H\u00f6kfelt","year":"1991","unstructured":"H\u00f6kfelt T. Neuropeptides in perspective: The last ten years. Neuron. 1991;7:867\u201379. https:\/\/doi.org\/10.1016\/0896-6273(91)90333-U","journal-title":"Neuron"},{"key":"399_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1258\/ebm.2009.009e01","volume":"228","author":"MM Berglund","year":"2003","unstructured":"Berglund MM, Hipskind PA, Gehlert DR. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp Biol Med (Maywood). 2003;228:217\u201344. https:\/\/doi.org\/10.1258\/ebm.2009.009e01","journal-title":"Exp Biol Med (Maywood)"},{"key":"399_CR14","doi-asserted-by":"publisher","first-page":"8169","DOI":"10.1523\/JNEUROSCI.17-21-08169.1997","volume":"17","author":"J Qian","year":"1997","unstructured":"Qian J, Colmers WF, Saggau P. Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry. J Neurosci. 1997;17:8169\u201377.","journal-title":"J Neurosci"},{"key":"399_CR15","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1523\/JNEUROSCI.21-15-05804.2001","volume":"21","author":"S Furtinger","year":"2001","unstructured":"Furtinger S, Pirker S, Czech T, Baumgartner C, Ransmayr G, Sperk G. Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy. J Neurosci. 2001;21:5804\u201312.","journal-title":"J Neurosci"},{"key":"399_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1535-7597.2003.03208.x","volume":"3","author":"WF Colmers","year":"2003","unstructured":"Colmers WF, El Bahh B. Neuropeptide Y and epilepsy. Epilepsy Curr. 2003;3:53\u20138. https:\/\/doi.org\/10.1046\/j.1535-7597.2003.03208.x","journal-title":"Epilepsy Curr"},{"key":"399_CR17","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1038\/sj.gt.3303013","volume":"14","author":"S Foti","year":"2007","unstructured":"Foti S, Haberman RP, Samulski RJ, McCown TJ. Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo. Gene Ther. 2007;14:1534\u20136. https:\/\/doi.org\/10.1038\/sj.gt.3303013","journal-title":"Gene Ther"},{"key":"399_CR18","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1093\/brain\/awn079","volume":"131","author":"F No\u00e8","year":"2008","unstructured":"No\u00e8 F, Pool AH, Nissinen J, Gobbi M, Bland R, Rizzi M, et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain. 2008;131:1506\u201315. https:\/\/doi.org\/10.1093\/brain\/awn079","journal-title":"Brain"},{"key":"399_CR19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.expneurol.2008.10.015","volume":"215","author":"AT S\u00f8rensen","year":"2009","unstructured":"S\u00f8rensen AT, Nikitidou L, Ledri M, Lin E-JJD, During MJ, Kanter-Schlifke I, et al. Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP. Exp Neurol. 2009;215:328\u201333. https:\/\/doi.org\/10.1016\/j.expneurol.2008.10.015","journal-title":"Exp Neurol"},{"key":"399_CR20","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/gt.2010.23","volume":"17","author":"F Noe","year":"2010","unstructured":"Noe F, Vaghi V, Balducci C, Fitzsimons H, Bland R, Zardoni D, et al. Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide y overexpression in rat hippocampus. Gene Ther. 2010;17:643\u201352. https:\/\/doi.org\/10.1038\/gt.2010.23","journal-title":"Gene Ther"},{"key":"399_CR21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.nbd.2018.01.016","volume":"113","author":"KL Powell","year":"2018","unstructured":"Powell KL, Fitzgerald X, Shallue C, Jovanovska V, Klugmann M, Von Jonquieres G, et al. Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model. Neurobiol Dis. 2018;113:23\u201332. https:\/\/doi.org\/10.1016\/j.nbd.2018.01.016","journal-title":"Neurobiol Dis"},{"key":"399_CR22","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.yebeh.2013.09.013","volume":"38","author":"M Simonato","year":"2014","unstructured":"Simonato M. Gene therapy for epilepsy. Epilepsy Behav. 2014;38:125\u201330. https:\/\/doi.org\/10.1016\/j.yebeh.2013.09.013","journal-title":"Epilepsy Behav"},{"key":"399_CR23","doi-asserted-by":"publisher","unstructured":"Cattaneo S, Verlengia G, Marino P, Simonato M, Bettegazzi B. NPY and Gene Therapy for Epilepsy: How, When,\u2026 and Y. Front Mol Neurosci. 2021;13. https:\/\/doi.org\/10.3389\/fnmol.2020.608001.","DOI":"10.3389\/fnmol.2020.608001"},{"key":"399_CR24","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1093\/brain\/awq219","volume":"133","author":"DPD Woldbye","year":"2010","unstructured":"Woldbye DPD, \u00c4ngehagen M, G\u00f8tzsche CR, Elbr\u00f8nd-Bek H, S\u00f8rensen AT, Christiansen SH, et al. Adeno-associated viral vector-induced overexpression of neuropeptide y Y2 receptors in the hippocampus suppresses seizures. Brain. 2010;133:2778\u201388. https:\/\/doi.org\/10.1093\/brain\/awq219","journal-title":"Brain"},{"key":"399_CR25","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nbd.2015.11.014","volume":"86","author":"L Nikitidou Ledri","year":"2016","unstructured":"Nikitidou Ledri L, Melin E, Christiansen SH, G\u00f8tzsche CR, Cifra A, Woldbye DPD, et al. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors. Neurobiol Dis. 2016;86:52\u201361. https:\/\/doi.org\/10.1016\/j.nbd.2015.11.014","journal-title":"Neurobiol Dis"},{"key":"399_CR26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.omtm.2019.09.004","volume":"15","author":"E Melin","year":"2019","unstructured":"Melin E, Nanobashvili A, Avdic U, G\u00f8tzsche CR, Andersson M, Woldbye DPD, et al. Disease modification by combinatorial single vector gene therapy: A preclinical translational study in epilepsy. Mol Ther - Methods Clin Dev. 2019;15:179\u201393. https:\/\/doi.org\/10.1016\/j.omtm.2019.09.004","journal-title":"Mol Ther - Methods Clin Dev"},{"key":"399_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0076310","volume":"8","author":"DF Aschauer","year":"2013","unstructured":"Aschauer DF, Kreuz S, Rumpel S. Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain. PLoS One. 2013;8:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0076310","journal-title":"PLoS One"},{"key":"399_CR28","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","volume":"10","author":"C Burger","year":"2004","unstructured":"Burger C, Gorbatyuk OS, Velardo MJ, Peden CS, Williams P, Zolotukhin S, et al. Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol Ther. 2004;10:302\u201317. https:\/\/doi.org\/10.1016\/j.ymthe.2004.05.024","journal-title":"Mol Ther"},{"key":"399_CR29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/mthe.2000.0050","volume":"1","author":"H Mizuguchi","year":"2000","unstructured":"Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther. 2000;1:376\u201382. https:\/\/doi.org\/10.1006\/mthe.2000.0050","journal-title":"Mol Ther"},{"key":"399_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0143-4179(83)90049-5","volume":"170","author":"G Paxinos","year":"2007","unstructured":"Paxinos G, Watson C. The rat brain in stereotaxic coordinates sixth edition. Elsevier Acad Press. 2007;170:547\u2013612. https:\/\/doi.org\/10.1016\/0143-4179(83)90049-5","journal-title":"Elsevier Acad Press"},{"key":"399_CR31","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.2337\/db07-1658","volume":"57","author":"AM Van Den Hoek","year":"2008","unstructured":"Van Den Hoek AM, Van Heijningen C, Schr\u00f6der-van Der Elst JP, Ouwens DM, Havekes LM, Romijn JA, et al. Intracerebroventricular administration of neuropeptide Y induces hepatic insulin resistance via sympathetic innervation. Diabetes. 2008;57:2304\u201310. https:\/\/doi.org\/10.2337\/db07-1658","journal-title":"Diabetes"},{"key":"399_CR32","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/oby.2008.670","volume":"17","author":"B Tiesjema","year":"2009","unstructured":"Tiesjema B, La Fleur SE, Luijendijk MCM, Adan RAH. Sustained NPY overexpression in the PVN results in obesity via temporarily increasing food intake. Obesity. 2009;17:1448\u201350. https:\/\/doi.org\/10.1038\/oby.2008.670","journal-title":"Obesity"},{"key":"399_CR33","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5483\/BMBRep.2015.48.4.272","volume":"48","author":"JW Sohn","year":"2015","unstructured":"Sohn JW. Network of hypothalamic neurons that control appetite. BMB Rep. 2015;48:229\u201333. https:\/\/doi.org\/10.5483\/BMBRep.2015.48.4.272","journal-title":"BMB Rep"},{"key":"399_CR34","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","volume":"32","author":"RJ Racine","year":"1972","unstructured":"Racine RJ. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972;32:281\u201394. https:\/\/doi.org\/10.1016\/0013-4694(72)90177-0","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"399_CR35","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1073\/pnas.92.16.7242","volume":"92","author":"LJ Sim","year":"1995","unstructured":"Sim LJ, Selley DE, Childers SR. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5\u2019-[gamma-[35S]thio]-triphosphate binding. Proc Natl Acad Sci USA. 1995;92:7242\u20136. https:\/\/doi.org\/10.1073\/pnas.92.16.7242","journal-title":"Proc Natl Acad Sci USA"},{"key":"399_CR36","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/jnr.21028","volume":"84","author":"DZ Christensen","year":"2006","unstructured":"Christensen DZ, Olesen MV, Kristiansen H, Mikkelsen JD, Woldbye DPD. Unaltered neuropeptide Y (NPY)-stimulated [35S]GTP\u03b3S binding suggests a net increase in NPY signalling after repeated electroconvulsive seizures in mice. J Neurosci Res. 2006;84:1282\u201391. https:\/\/doi.org\/10.1002\/jnr.21028","journal-title":"J Neurosci Res"},{"key":"399_CR37","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/hipo.20415","volume":"18","author":"AT S\u00f8rensen","year":"2008","unstructured":"S\u00f8rensen AT, Kanter-Schlifke I, Carli M, Balducci C, Noe F, During MJ, et al. NPY gene transfer in the hippocampus attenuates synaptic plasticity and learning. Hippocampus. 2008;18:564\u201374. https:\/\/doi.org\/10.1002\/hipo.20415","journal-title":"Hippocampus"},{"key":"399_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-56062-1","volume":"9","author":"J Wickham","year":"2019","unstructured":"Wickham J, Ledri M, Bengzon J, Jespersen B, Pinborg LH, Englund E, et al. Inhibition of epileptiform activity by neuropeptide Y in brain tissue from drug-resistant temporal lobe epilepsy patients. Sci Rep. 2019;9:1\u201311. https:\/\/doi.org\/10.1038\/s41598-019-56062-1","journal-title":"Sci Rep"},{"key":"399_CR39","doi-asserted-by":"publisher","first-page":"9622","DOI":"10.1523\/JNEUROSCI.3973-14.2015","volume":"35","author":"M Ledri","year":"2015","unstructured":"Ledri M, Sorensen AT, Madsen MG, Christiansen SH, Ledri LN, Cifra A, et al. Differential effect of neuropeptides on excitatory synaptic transmission in human epileptic hippocampus. J Neurosci. 2015;35:9622\u201331. https:\/\/doi.org\/10.1523\/JNEUROSCI.3973-14.2015","journal-title":"J Neurosci"},{"key":"399_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2020.603409","volume":"13","author":"JA Szczygie\u0142","year":"2020","unstructured":"Szczygie\u0142 JA, Danielsen KI, Melin E, Rosenkranz SH, Pankratova S, Ericsson A, et al. Gene therapy vector encoding neuropeptide Y and its receptor Y2 for future treatment of epilepsy: Preclinical data in rats. Front Mol Neurosci. 2020;13:1\u201313. https:\/\/doi.org\/10.3389\/fnmol.2020.603409","journal-title":"Front Mol Neurosci"},{"key":"399_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.physiol.64.092501.114547","volume":"64","author":"RS Zucker","year":"2002","unstructured":"Zucker RS, Regehr WG. Short-term synaptic plasticity. Annu Rev Physiol. 2002;64:355\u2013405. https:\/\/doi.org\/10.1146\/annurev.physiol.64.092501.114547","journal-title":"Annu Rev Physiol"},{"key":"399_CR42","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/j.1476-5381.1994.tb17055.x","volume":"113","author":"S Greber","year":"1994","unstructured":"Greber S, Schwarzer C, Sperk G. Neuropeptide Y inhibits potassium\u2010stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro. Br J Pharmacol. 1994;113:737\u201340. https:\/\/doi.org\/10.1111\/j.1476-5381.1994.tb17055.x","journal-title":"Br J Pharmacol"},{"key":"399_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.mcn.2008.06.014","volume":"39","author":"AT S\u00f8rensen","year":"2008","unstructured":"S\u00f8rensen AT, Kanter-Schlifke I, Lin EJD, During MJ, Kokaia M. Activity-dependent volume transmission by transgene NPY attenuates glutamate release and LTP in the subiculum. Mol Cell Neurosci. 2008;39:229\u201337. https:\/\/doi.org\/10.1016\/j.mcn.2008.06.014","journal-title":"Mol Cell Neurosci"},{"key":"399_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-12-87","volume":"12","author":"MS Andersson","year":"2011","unstructured":"Andersson MS, Hanse E. Astrocyte-mediated short-term synaptic depression in the rat hippocampal CA1 area: two modes of decreasing release probability. BMC Neurosci. 2011;12:87. https:\/\/doi.org\/10.1186\/1471-2202-12-87","journal-title":"BMC Neurosci"},{"key":"399_CR45","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/266737a0","volume":"266","author":"GS Lynch","year":"1977","unstructured":"Lynch GS, Dunwiddie T, Gribkoff V. Heterosynaptic depression: a postsynaptic correlate of long-term potentiation. Nature. 1977;266:737\u20139. https:\/\/doi.org\/10.1038\/266737a0","journal-title":"Nature"},{"key":"399_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0928-4257(97)81416-7","volume":"90","author":"M Scanziani","year":"1996","unstructured":"Scanziani M, Nicoll R, Malenka R. Heterosynaptic long-term depression in the hippocampus. J Physiol. 1996;90:165\u20136. https:\/\/doi.org\/10.1016\/S0928-4257(97)81416-7","journal-title":"J Physiol"},{"key":"399_CR47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/syn.890150207","volume":"15","author":"LM Grover","year":"1993","unstructured":"Grover LM, Teyler TJ. Presynaptic mechanism for heterosynaptic, posttetanic depression in area CA1 of rat hippocampus. Synapse. 1993;15:149\u201357. https:\/\/doi.org\/10.1002\/syn.890150207","journal-title":"Synapse"},{"key":"399_CR48","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1126\/science.7916485","volume":"265","author":"OJ Manzoni","year":"1994","unstructured":"Manzoni OJ, Manabe T, Nicoll RA. Release of adenosine by activation of NMDA receptors in the hippocampus. Science. 1994;265:2098\u2013101. https:\/\/doi.org\/10.1126\/science.7916485","journal-title":"Science"},{"key":"399_CR49","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0896-6273(03)00717-7","volume":"40","author":"J Zhang","year":"2003","unstructured":"Zhang J, Wang H, Ye C, Ge W, Chen Y, Jiang Z, et al. ATP released by astrocytes mediates glutamatergic activity-dependent heterosynaptic suppression. Neuron. 2003;40:971\u201382. https:\/\/doi.org\/10.1016\/S0896-6273(03)00717-7","journal-title":"Neuron"},{"key":"399_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1126\/science.1116916","volume":"310","author":"O Pascual","year":"2005","unstructured":"Pascual O, Casper KB, Kubera C, Zhang J, Revilla-Sanchez R, Sul J-Y, et al. Astrocytic purinergic signaling coordinates synaptic networks. Science. 2005;310:113\u20136. https:\/\/doi.org\/10.1126\/science.1116916","journal-title":"Science"},{"key":"399_CR51","doi-asserted-by":"publisher","first-page":"5370","DOI":"10.1523\/JNEUROSCI.5255-05.2006","volume":"26","author":"A Serrano","year":"2006","unstructured":"Serrano A, Haddjeri N, Lacaille J-C, Robitaille R. GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression. J Neurosci. 2006;26:5370\u201382. https:\/\/doi.org\/10.1523\/JNEUROSCI.5255-05.2006","journal-title":"J Neurosci"},{"key":"399_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1460-9568.1989.tb00803.x","volume":"1","author":"B Gustafsson","year":"1989","unstructured":"Gustafsson B, Asztely F, Hanse E, Wigstrom H. Onset characteristics of long-term potentiation in the Guinea-Pig hippocampal CA1 region in vitro. Eur J Neurosci. 1989;1:382\u201394. https:\/\/doi.org\/10.1111\/j.1460-9568.1989.tb00803.x","journal-title":"Eur J Neurosci"},{"key":"399_CR53","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0896-6273(93)90308-E","volume":"10","author":"JS Isaacson","year":"1993","unstructured":"Isaacson JS, Solis JM, Nicoll RA. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron. 1993;10:165\u201375. https:\/\/doi.org\/10.1016\/0896-6273(93)90308-E","journal-title":"Neuron"},{"key":"399_CR54","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1113\/jphysiol.2007.142737","volume":"585","author":"M Andersson","year":"2007","unstructured":"Andersson M, Blomstrand F, Hanse E. Astrocytes play a critical role in transient heterosynaptic depression in the rat hippocampal CA1 region. J Physiol. 2007;585:843\u201352. https:\/\/doi.org\/10.1113\/jphysiol.2007.142737","journal-title":"J Physiol"},{"key":"399_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep24818","volume":"6","author":"M Andersson","year":"2016","unstructured":"Andersson M, Avaliani N, Svensson A, Wickham J, Pinborg LH, Jespersen B, et al. Optogenetic control of human neurons in organotypic brain cultures. Sci Rep. 2016;6:1\u20135. https:\/\/doi.org\/10.1038\/srep24818","journal-title":"Sci Rep"},{"key":"399_CR56","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.neures.2014.09.002","volume":"93","author":"A Watakabe","year":"2015","unstructured":"Watakabe A, Ohtsuka M, Kinoshita M, Takaji M, Isa K, Mizukami H, et al. Comparative analyses of adeno-associated viral vector serotypes 1, 2, 5, 8 and 9 in marmoset, mouse and macaque cerebral cortex. Neurosci Res. 2015;93:144\u201357. https:\/\/doi.org\/10.1016\/j.neures.2014.09.002","journal-title":"Neurosci Res"},{"key":"399_CR57","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/humc.2019.030","volume":"30","author":"T He","year":"2019","unstructured":"He T, Itano MS, Earley LF, Hall NE, Riddick N, Samulski RJ, et al. The Influence of Murine Genetic Background in Adeno-Associated Virus Transduction of the Mouse Brain. Hum Gene Ther Clin Dev. 2019;30:169\u201381. https:\/\/doi.org\/10.1089\/humc.2019.030","journal-title":"Hum Gene Ther Clin Dev"},{"key":"399_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.seizure.2017.12.005","volume":"55","author":"MI Patr\u00edcio","year":"2018","unstructured":"Patr\u00edcio MI, Barnard AR, Green AL, During MJ, Sen A, MacLaren RE. A clinical-grade gene therapy vector for pharmacoresistant epilepsy successfully overexpresses NPY in a human neuronal cell line. Seizure. 2018;55:25\u20139. https:\/\/doi.org\/10.1016\/j.seizure.2017.12.005","journal-title":"Seizure"},{"key":"399_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-22554-9","volume":"8","author":"J Wickham","year":"2018","unstructured":"Wickham J, Br\u00f6djeg\u00e5rd NG, Vighagen R, Pinborg LH, Bengzon J, Woldbye DPD, et al. Prolonged life of human acute hippocampal slices from temporal lobe epilepsy surgery. Sci Rep. 2018;8:1\u201313. https:\/\/doi.org\/10.1038\/s41598-018-22554-9","journal-title":"Sci Rep"},{"key":"399_CR60","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nm0797-761","volume":"3","author":"DPD Woldbye","year":"1997","unstructured":"Woldbye DPD, Larsen PJ, Mikkelsen JD, Klemp K, Madsen TM, Bolwig TG. Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5- like receptors. Nat Med. 1997;3:761\u20134. https:\/\/doi.org\/10.1038\/nm0797-761","journal-title":"Nat Med"},{"key":"399_CR61","doi-asserted-by":"publisher","first-page":"13518","DOI":"10.1073\/pnas.96.23.13518","volume":"96","author":"DJ Marsh","year":"1999","unstructured":"Marsh DJ, Baraban SC, Hollopeter G, Palmiter RD. Role of the Y5 neuropeptide Y receptor in limbic seizures. Proc Natl Acad Sci USA. 1999;96:13518\u201323. https:\/\/doi.org\/10.1073\/pnas.96.23.13518","journal-title":"Proc Natl Acad Sci USA"},{"key":"399_CR62","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/jnr.22770","volume":"90","author":"MV Olesen","year":"2012","unstructured":"Olesen MV, Christiansen SH, G\u00f8tzsche CR, Nikitidou L, Kokaia M, Woldbye DPD. Neuropeptide Y Y1 receptor hippocampal overexpression via viral vectors is associated with modest anxiolytic-like and proconvulsant effects in mice. J Neurosci Res. 2012;90:498\u2013507. https:\/\/doi.org\/10.1002\/jnr.22770","journal-title":"J Neurosci Res"},{"key":"399_CR63","doi-asserted-by":"publisher","first-page":"101979","DOI":"10.1016\/j.npep.2019.101979","volume":"79","author":"KM Corder","year":"2020","unstructured":"Corder KM, Li Q, Cortes MA, Bartley AF, Davis TR, Dobrunz LE. Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y. Neuropeptides. 2020;79:101979. https:\/\/doi.org\/10.1016\/j.npep.2019.101979","journal-title":"Neuropeptides"},{"key":"399_CR64","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1038\/sj.gt.3301529","volume":"8","author":"R Xu","year":"2001","unstructured":"Xu R, Janson CG, Mastakov M, Lawlor P, Young D, Mouravlev A, et al. Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes. Gene Ther. 2001;8:1323\u201332. https:\/\/doi.org\/10.1038\/sj.gt.3301529","journal-title":"Gene Ther"},{"key":"399_CR65","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/hum.2006.178","volume":"18","author":"JM Taymans","year":"2007","unstructured":"Taymans JM, Vandenberghe LH, Van Den Haute C, Thiry I, Deroose CM, Mortelmans L, et al. Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum Gene Ther. 2007;18:195\u2013206. https:\/\/doi.org\/10.1089\/hum.2006.178","journal-title":"Hum Gene Ther"},{"key":"399_CR66","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.coviro.2017.06.003","volume":"24","author":"S Pillay","year":"2017","unstructured":"Pillay S, Carette JE. Host determinants of adeno-associated viral vector entry. Curr Opin Virol. 2017;24:124\u201331. https:\/\/doi.org\/10.1016\/j.coviro.2017.06.003","journal-title":"Curr Opin Virol"},{"key":"399_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2006.09.042","volume":"1122","author":"SF Li","year":"2006","unstructured":"Li SF, Wang RZ, Meng QH, Li GL, Hu GJ, Dou WC, et al. Intra-ventricular infusion of rAAV1-EGFP resulted in transduction in multiple regions of adult rat brain: A comparative study with rAAV2 and rAAV5 vectors. Brain Res. 2006;1122:1\u20139. https:\/\/doi.org\/10.1016\/j.brainres.2006.09.042","journal-title":"Brain Res"},{"key":"399_CR68","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/0306-4522(86)90057-6","volume":"18","author":"ME de Quidt","year":"1986","unstructured":"de Quidt ME, Emson PC. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system-II. Immunohistochemical analysis. Neuroscience. 1986;18:545\u2013618. https:\/\/doi.org\/10.1016\/0306-4522(86)90057-6","journal-title":"Neuroscience"},{"key":"399_CR69","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0166-2236(98)01284-3","volume":"22","author":"A Vezzani","year":"1999","unstructured":"Vezzani A, Sperk G, Colmers WF. Neuropeptide Y: Emerging evidence for a functional role in seizure modulation. Trends Neurosci. 1999;22:25\u201330.","journal-title":"Trends Neurosci"},{"key":"399_CR70","doi-asserted-by":"publisher","first-page":"23 LP","DOI":"10.1523\/JNEUROSCI.2599-16.2016","volume":"37","author":"Q Li","year":"2017","unstructured":"Li Q, Bartley AF, Dobrunz LE. Endogenously released neuropeptide Y suppresses hippocampal short-term facilitation and is impaired by stress-induced anxiety. J Neurosci. 2017;37:23 LP\u201337. https:\/\/doi.org\/10.1523\/JNEUROSCI.2599-16.2016","journal-title":"J Neurosci"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-023-00399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-023-00399-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-023-00399-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T13:08:35Z","timestamp":1692968915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-023-00399-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,7]]},"references-count":70,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["399"],"URL":"https:\/\/doi.org\/10.1038\/s41434-023-00399-w","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,7]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was sponsored by the spin-off company CombiGene AB. MK and DPDW are co-founders, shareowners, and consultants of CombiGene AB. Esbj\u00f6rn Melin is employed and has shares in CombiGene AB.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}